UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000019268
Receipt number R000022283
Scientific Title A phase II study of TAS102 for advanced/recurrent esophageal cancer resistant/intolerable to 5-FU, Platinum compounds, and Taxane
Date of disclosure of the study information 2015/10/13
Last modified on 2018/05/08 21:51:11

No. Disposal Last modified on Item of update
1 Insert 2015/10/07 20:00:12
2 Update 2015/10/07 21:10:25 UMIN ID1
3 Update 2015/10/07 22:00:05 Public title
Acronym
4 Update 2015/10/07 22:10:26 Condition
Condition
Narrative objectives1
Primary outcomes
Key secondary outcomes
5 Update 2015/10/07 22:21:39 Interventions/Control_1
Key inclusion criteria
6 Update 2015/10/07 22:35:20 Address
Address
Address
7 Update 2015/10/07 22:35:38 Key inclusion criteria
8 Update 2015/10/08 10:26:42 Public title
Acronym
9 Update 2015/10/08 12:48:24 Key inclusion criteria
Key exclusion criteria
10 Update 2015/10/08 12:55:11 Key exclusion criteria
11 Update 2015/10/08 12:58:37 Narrative objectives1
12 Update 2015/10/08 13:34:07 Public title
Acronym
13 Update 2015/10/08 18:35:43 Narrative objectives1
14 Update 2015/10/08 18:42:30 Key inclusion criteria
Key exclusion criteria
15 Update 2015/10/13 15:51:16 Date of disclosure of the study information
16 Update 2015/10/26 13:44:53 Institutions
17 Update 2015/10/29 22:58:50 Institutions
18 Update 2015/11/06 22:12:58 Recruitment status
19 Update 2015/11/19 17:21:09 Institutions
20 Update 2015/11/24 12:33:32 Institutions
21 Update 2016/05/31 22:33:21 Recruitment status
22 Update 2017/06/06 15:20:14 Last follow-up date
Date of closure to data entry
23 Update 2017/06/21 23:44:11 Recruitment status
24 Update 2018/05/08 21:48:10 Name of primary person or sponsor
Organization
25 Update 2018/05/08 21:49:00 Date trial data considered complete
Date analysis concluded
26 Update 2018/05/08 21:51:11 Key exclusion criteria